Toung Loong Textile Mfg.Co.,Ltd. (TPEX:4401)
Taiwan · Delayed Price · Currency is TWD 15.70
+0.10 (0.64%)
Aug 1, 2025, 1:30 PM CST
Ligand Pharmaceuticals Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 4,012 | 3,922 | 2,818 | 4,100 | 5,024 | 3,152 | Upgrade | |
Revenue Growth (YoY) | 30.85% | 39.16% | -31.26% | -18.40% | 59.42% | -11.56% | Upgrade |
Cost of Revenue | 3,658 | 3,582 | 2,647 | 3,659 | 4,386 | 2,900 | Upgrade |
Gross Profit | 353.85 | 339.57 | 171.61 | 440.58 | 638.77 | 252.14 | Upgrade |
Selling, General & Admin | 196.19 | 195.72 | 169.54 | 212.3 | 202.67 | 167.65 | Upgrade |
Research & Development | 15.78 | 15.65 | 15.01 | 15.17 | 14.96 | 12.69 | Upgrade |
Operating Expenses | 210.45 | 211.09 | 180.92 | 229.84 | 216.34 | 177.55 | Upgrade |
Operating Income | 143.4 | 128.48 | -9.31 | 210.75 | 422.43 | 74.59 | Upgrade |
Interest Expense | -41.24 | -41.71 | -43 | -29.34 | -24.74 | -26.37 | Upgrade |
Interest & Investment Income | 19.19 | 21.24 | 22.81 | 21.24 | 7.99 | 8.9 | Upgrade |
Earnings From Equity Investments | -2.21 | -3 | -9.14 | -8.91 | -1.94 | -0.02 | Upgrade |
Currency Exchange Gain (Loss) | 16.04 | 34.74 | 1.39 | 39.36 | -17.03 | -36.66 | Upgrade |
Other Non Operating Income (Expenses) | 29.47 | 29.05 | 24.62 | -21.04 | 26.26 | 74.06 | Upgrade |
EBT Excluding Unusual Items | 164.65 | 168.8 | -12.62 | 212.05 | 412.96 | 94.5 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | -2.12 | -1.02 | 1.53 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 0.03 | -4.18 | -2.77 | -0.29 | Upgrade |
Pretax Income | 164.65 | 168.8 | -12.59 | 205.75 | 409.16 | 95.74 | Upgrade |
Income Tax Expense | 32.14 | 35.79 | -0.44 | 33.45 | 87.37 | 9.38 | Upgrade |
Earnings From Continuing Operations | 132.51 | 133.01 | -12.15 | 172.3 | 321.79 | 86.36 | Upgrade |
Minority Interest in Earnings | -3.42 | -2.73 | -3.76 | -4.73 | -4.15 | -1.92 | Upgrade |
Net Income | 129.08 | 130.28 | -15.91 | 167.57 | 317.64 | 84.44 | Upgrade |
Net Income to Common | 129.08 | 130.28 | -15.91 | 167.57 | 317.64 | 84.44 | Upgrade |
Net Income Growth | 498.61% | - | - | -47.24% | 276.17% | -59.85% | Upgrade |
Shares Outstanding (Basic) | 123 | 123 | 123 | 123 | 123 | 123 | Upgrade |
Shares Outstanding (Diluted) | 123 | 123 | 123 | 123 | 123 | 123 | Upgrade |
EPS (Basic) | 1.05 | 1.06 | -0.13 | 1.37 | 2.59 | 0.69 | Upgrade |
EPS (Diluted) | 1.05 | 1.06 | -0.13 | 1.37 | 2.59 | 0.69 | Upgrade |
EPS Growth | 498.61% | - | - | -47.24% | 276.17% | -59.85% | Upgrade |
Free Cash Flow | 205.32 | 227.69 | 140.31 | 16.91 | 382.71 | -94.69 | Upgrade |
Free Cash Flow Per Share | 1.67 | 1.86 | 1.14 | 0.14 | 3.12 | -0.77 | Upgrade |
Dividend Per Share | 0.700 | 0.700 | 0.500 | 0.700 | 1.274 | 0.980 | Upgrade |
Dividend Growth | 40.00% | 40.00% | -28.57% | -45.08% | 30.00% | -16.67% | Upgrade |
Gross Margin | 8.82% | 8.66% | 6.09% | 10.75% | 12.71% | 8.00% | Upgrade |
Operating Margin | 3.57% | 3.28% | -0.33% | 5.14% | 8.41% | 2.37% | Upgrade |
Profit Margin | 3.22% | 3.32% | -0.56% | 4.09% | 6.32% | 2.68% | Upgrade |
Free Cash Flow Margin | 5.12% | 5.81% | 4.98% | 0.41% | 7.62% | -3.00% | Upgrade |
EBITDA | 453.49 | 444.16 | 335.21 | 562.39 | 792.26 | 404.15 | Upgrade |
EBITDA Margin | 11.30% | 11.33% | 11.89% | 13.72% | 15.77% | 12.82% | Upgrade |
D&A For EBITDA | 310.09 | 315.68 | 344.52 | 351.65 | 369.83 | 329.56 | Upgrade |
EBIT | 143.4 | 128.48 | -9.31 | 210.75 | 422.43 | 74.59 | Upgrade |
EBIT Margin | 3.57% | 3.28% | -0.33% | 5.14% | 8.41% | 2.37% | Upgrade |
Effective Tax Rate | 19.52% | 21.20% | - | 16.26% | 21.35% | 9.79% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.